Edition:
United Kingdom

Santen Pharmaceutical Co Ltd (4536.T)

4536.T on Tokyo Stock Exchange

1,843JPY
23 Aug 2019
Change (% chg)

¥-3 (-0.16%)
Prev Close
¥1,846
Open
¥1,828
Day's High
¥1,852
Day's Low
¥1,819
Volume
1,016,300
Avg. Vol
1,049,742
52-wk High
¥1,988
52-wk Low
¥1,450

Summary

Name Age Since Current Position

Akira Kurokawa

66 2018 Chairman of the Board, Chief Executive Officer, Representative Director

Shigeo Taniuchi

45 2019 President, Chief Operating Officer, Representative Director

Kazuo Koshiji

2017 Chief Financial Officer, Managing Executive Officer, Chief Director of Finance & Administration

Noriaki Yamamoto

Chief Information Officer, Executive Officer, Chief Director of Information System

Naveed Shams

2017 Chief Scientific Officer, Managing Executive Officer, Chief Director of Research & Development

Masamichi Sato

2017 Managing Executive Officer, Chief Compliance Officer, Chief Director of CSR & Internal Control, President of Subsidiary

Takeshi Ito

59 2019 Senior Managing Executive Officer, Director of Ophthalmology Business, Director

Akihiro Tsujimura

51 2017 Senior Managing Executive Officer, Director of Asia Business, President & Chief Executive Officer of Subsidiary, Director

Akio Kimura

2018 Managing Executive Officer, Chief Director of Production

Atsutoshi Ohta

Managing Executive Officer, Chief Director of Human Resources & Organization Development

Satoshi Suzuki

2018 Managing Executive Officer, Chief Director of Planning

Takahiro Morita

2018 Executive Officer, Senior Director of Sales in Ophthalmology Business Unit

Miki Fujima

2019 Executive Officer, Chief Director of Human Resources

Ken Araki

2018 Executive Officer, Senior Director of Global Business Development

Frank Binder

2018 Executive Officer, Chief Director of Supply Chain

Luis Iglesias

2018 Executive Officer

Ye Liu

Executive Officer, General Manager of Subsidiary

Kenji Morishima

2018 Executive Officer, Senior Director of Product Research in Main Research & Development Unit

Ko Takahashi

2019 Executive Officer

Kunihito Minakawa

64 2018 Independent Director

Kanoko Ohishi

58 2015 Independent Director

Yutaro Shintaku

63 2017 Independent Director

Hidetaka Mizutani

2017 Manager of Finance & Accounting Group

Biographies

Name Description

Akira Kurokawa

Mr. Akira Kurokawa has been serving as Chairman of the Board, Chief Executive Officer and Representative Director in Santen Pharmaceutical Co., Ltd. since April 1, 2018. He joined the Company in April 1977. His previous titles include Director of Pharmaceutical Business, Executive Officer, Managing Executive Officer and Chief Operating Officer in the Company. He used to serve as President and Director in a subsidiary, Santen Holdings U.S. Inc.

Shigeo Taniuchi

Mr. Shigeo Taniuchi was named President, Chief Operating Officer and Representative Director in Santen Pharmaceutical Co., Ltd., effective April 1, 2019. He joined the Company in April 1996. His previous titles include Executive Officer, Assistant Manager of China Business Supervisor Office in Asia Business Unit, Manager of Business Planning & Administration Office in Asia Business Unit, Manager of Business Planning Office in Main Planning Unit and Deputy Chief Director of Planning in the Company.

Kazuo Koshiji

Noriaki Yamamoto

Naveed Shams

Masamichi Sato

Takeshi Ito

Mr. Takeshi Ito has been serving as Senior Managing Executive Officer, Director of Ophthalmology Business and Director in Santen Pharmaceutical Co., Ltd. effective April 1, 2019. He joined the Company in April 1982. His previous titles include Executive Officer, Managing Executive Officer, Manager of Business Development Office in Main Business Development Unit, Manager of Planning Office in Research & Development Strategy Supervisor Unit, Director of Surgical Business, Senior Director of Research & Development in Main Research & Development Unit and Senior Director of Pharmaceutical Sales in Pharmaceutical Business Unit in the Company.

Akihiro Tsujimura

Mr. Akihiro Tsujimura has been serving as Senior Managing Executive Officer, Director of Asia Business and Director in Santen Pharmaceutical Co., Ltd., as well as President and Chief Executive Officer of a subsidiary, Santen Inc., since June 23, 2017. He joined the Company in August 2004. His previous titles include Executive Officer, Managing Executive Officer, Director of Business Development and Chief Director of Planning in the Company.

Akio Kimura

Atsutoshi Ohta

Satoshi Suzuki

Takahiro Morita

Miki Fujima

Ken Araki

Frank Binder

Luis Iglesias

Ye Liu

Kenji Morishima

Ko Takahashi

Kunihito Minakawa

Mr. Kunihito Minakawa has been serving as Independent Director in Santen Pharmaceutical Co., Ltd. since June 2018. He is also serving as Independent Director in Sony Corporation.

Kanoko Ohishi

Ms. Kanoko Ohishi has been serving as Independent Director in Santen Pharmaceutical Co., Ltd. since June 2015. She is also serving as Independent Director in Ezaki Glico Company, Limited, and Shiseido Company, Limited, as well as Representative Director in Mediva Inc. and another company, and working for Plata-net. She used to work for McKinsey & Company, Inc. and Astellas Pharma Inc.

Yutaro Shintaku

Mr. Yutaro Shintaku has been serving as Independent Director in Santen Pharmaceutical Co., Ltd. since June 2017. He is also serving as Independent Director in J-OIL MILLS, INC. and KUBOTA Corporation, as well as working for TERUMO CORPORATION. He is also a Visiting Professor in Hitotsubashi University.

Hidetaka Mizutani